Position in MRK
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,919,237
+$528,773 QoQ
Shares Held
38,282
+4.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#1,052
of 3,766 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FOSTER & MOTLEY INC holds $58,493,564 across 11 Drug Manufacturers - General names. MRK ranks #4 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
57,981 | $14,590,338 | |
| 2 | AMGN |
Amgen Inc
|
32,896 | $11,912,299 | |
| 3 | JNJ |
Johnson & Johnson
|
45,340 | $11,514,999 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
38,282 | $4,919,237 | |
| 5 | PFE |
Pfizer Inc
|
168,239 | $4,051,195 | |
| 6 | NVS |
Novartis AG
|
21,447 | $3,361,173 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
56,454 | $3,252,879 | |
| 8 | GSK |
GSK plc
|
42,484 | $2,227,011 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,919,237 | 38,282 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $4,390,464 | 36,499 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $3,496,842 | 33,221 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $2,884,254 | 34,365 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $2,966,837 | 37,479 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $3,546,507 | 39,511 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $4,189,998 | 42,119 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $5,001,068 | 44,039 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $5,429,249 | 43,855 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $5,918,353 | 44,853 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $5,062,016 | 46,432 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $4,883,124 | 47,432 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $5,392,751 | 46,735 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $4,743,610 | 44,587 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $4,438,000 | 40,000 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,963,130 | 34,407 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $3,138,527 | 34,425 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,922,046 | 35,613 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $2,701,943 | 35,255 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $2,620,137 | 34,884 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $2,828,650 | 36,372 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $3,174,645 | 41,181 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $2,983,571 | 36,474 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $2,536,363 | 30,577 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $2,333,743 | 30,179 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $1,856,330 | 24,127 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||